CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing personalized cancer vaccines that target unique tumor mutations in individual patients. By investigating tumor heterogeneity at the single cell level, the research aims to enhance vaccine efficacy and create new diagnostic tools for cancer treatment.
Personalized cancer vaccines are therapeutic vaccines custom tailored to target tumor-specific mutations unique to a given patient.
Such a treatment offers great hope for cancer patients as it does not harm healthy cells and has the potential to provide life-long remission.
The emerging view of cancer as a dynamic evolutionary process that produces startling genetic heterogeneity and escapes treatment poses challenges for cancer vaccines.
Yet progress in elucidating the nature of tumor heterogen…
TRON - TRANSLATIONALE ONKOLOGIE ANDER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
